The University of Chicago Header Logo

Connection

Dezheng Huo to Carcinosarcoma

Back to Details
This is a "connection" page, showing publications Dezheng Huo has written about Carcinosarcoma.
Dezheng Huo
Connection Strength
0.087
Carcinosarcoma
  1. A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia. Gynecol Oncol. 2010 Apr; 117(1):37-40.
    View in: PubMed
    Score: 0.087
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.